ACP supports new CDC guidance for prescribing naloxone with opioids

Naloxone can reverse the effects of an opioid overdose if it is quickly administered.


ACP continues to support coprescribing naloxone when prescribing opioids, a stance consistent with recent FDA guidance and previously released guidelines from the CDC.

Naloxone can reverse the effects of an opioid overdose if it is quickly administered. According to the CDC, overdoses involving opioids killed more than 47,000 people in the United States in 2017, with 36% of those deaths involving prescription opioids.

ACP offers a variety of resources on opioid therapy. A related module in ACP's Online Learning Center provides video learning, prescribing modules, tips from ACP Practice Advisor, MKSAP, and patient education materials.

Annals of Internal Medicine has published several original research articles on opioids, which are accessible at annals.org.